This report aims to provide a comprehensive presentation of the global market for Anti-Migraine Drugs, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Anti-Migraine Drugs. This report contains market size and forecasts of Anti-Migraine Drugs in global, including the following market information:
Global Anti-Migraine Drugs Market Revenue, 2018-2023, 2024-2029, ($ millions)
Global Anti-Migraine Drugs Market Sales, 2018-2023, 2024-2029, (K Units)
Global top five Anti-Migraine Drugs companies in 2022 (%)
The global Anti-Migraine Drugs market was valued at US$ million in 2022 and is projected to reach US$ million by 2029, at a CAGR of % during the forecast period. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
The U.S. Market is Estimated at $ Million in 2022, While China is Forecast to Reach $ Million.
Triptans Segment to Reach $ Million by 2029, with a % CAGR in next six years.
The global key manufacturers of Anti-Migraine Drugs include Eli Lilly, Abbott, Eisai, Allergan, Endo, GlaxoSmithKline, Impax Laboratories, Pfizer and AstraZeneca, etc. in 2022, the global top five players have a share approximately % in terms of revenue.
We surveyed the Anti-Migraine Drugs manufacturers, suppliers, distributors and industry experts on this industry, involving the sales, revenue, demand, price change, product type, recent development and plan, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Anti-Migraine Drugs Market, by Type, 2018-2023, 2024-2029 ($ Millions) & (K Units)
Global Anti-Migraine Drugs Market Segment Percentages, by Type, 2022 (%)
Triptans
Ergots
Others
Global Anti-Migraine Drugs Market, by Application, 2018-2023, 2024-2029 ($ Millions) & (K Units)
Global Anti-Migraine Drugs Market Segment Percentages, by Application, 2022 (%)
Women
Men
Global Anti-Migraine Drugs Market, By Region and Country, 2018-2023, 2024-2029 ($ Millions) & (K Units)
Global Anti-Migraine Drugs Market Segment Percentages, By Region and Country, 2022 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Anti-Migraine Drugs revenues in global market, 2018-2023 (Estimated), ($ millions)
Key companies Anti-Migraine Drugs revenues share in global market, 2022 (%)
Key companies Anti-Migraine Drugs sales in global market, 2018-2023 (Estimated), (K Units)
Key companies Anti-Migraine Drugs sales share in global market, 2022 (%)
Further, the report presents profiles of competitors in the market, key players include:
Eli Lilly
Abbott
Eisai
Allergan
Endo
GlaxoSmithKline
Impax Laboratories
Pfizer
AstraZeneca
Bayer
Johnson & Johnson
Merck
Teva
Amgen
Outline of Major Chapters:
Chapter 1: Introduces the definition of Anti-Migraine Drugs, market overview.
Chapter 2: Global Anti-Migraine Drugs market size in revenue and volume.
Chapter 3: Detailed analysis of Anti-Migraine Drugs manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales of Anti-Migraine Drugs in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 8: Global Anti-Migraine Drugs capacity by region & country.
Chapter 9: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 10: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 11: The main points and conclusions of the report.
TABLE OF CONTENTS
1 Introduction to Research & Analysis Reports
1.1 Anti-Migraine Drugs Market Definition
1.2 Market Segments
1.2.1 Market by Type
1.2.2 Market by Application
1.3 Global Anti-Migraine Drugs Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 Global Anti-Migraine Drugs Overall Market Size
2.1 Global Anti-Migraine Drugs Market Size: 2022 VS 2029
2.2 Global Anti-Migraine Drugs Revenue, Prospects & Forecasts: 2018-2029
2.3 Global Anti-Migraine Drugs Sales: 2018-2029
3 Company Landscape
3.1 Top Anti-Migraine Drugs Players in Global Market
3.2 Top Global Anti-Migraine Drugs Companies Ranked by Revenue
3.3 Global Anti-Migraine Drugs Revenue by Companies
3.4 Global Anti-Migraine Drugs Sales by Companies
3.5 Global Anti-Migraine Drugs Price by Manufacturer (2018-2023)
3.6 Top 3 and Top 5 Anti-Migraine Drugs Companies in Global Market, by Revenue in 2022
3.7 Global Manufacturers Anti-Migraine Drugs Product Type
3.8 Tier 1, Tier 2 and Tier 3 Anti-Migraine Drugs Players in Global Market
3.8.1 List of Global Tier 1 Anti-Migraine Drugs Companies
3.8.2 List of Global Tier 2 and Tier 3 Anti-Migraine Drugs Companies
4 Sights by Product
4.1 Overview
4.1.1 By Type - Global Anti-Migraine Drugs Market Size Markets, 2022 & 2029
4.1.2 Triptans
4.1.3 Ergots
4.1.4 Others
4.2 By Type - Global Anti-Migraine Drugs Revenue & Forecasts
4.2.1 By Type - Global Anti-Migraine Drugs Revenue, 2018-2023
4.2.2 By Type - Global Anti-Migraine Drugs Revenue, 2024-2029
4.2.3 By Type - Global Anti-Migraine Drugs Revenue Market Share, 2018-2029
4.3 By Type - Global Anti-Migraine Drugs Sales & Forecasts
4.3.1 By Type - Global Anti-Migraine Drugs Sales, 2018-2023
4.3.2 By Type - Global Anti-Migraine Drugs Sales, 2024-2029
4.3.3 By Type - Global Anti-Migraine Drugs Sales Market Share, 2018-2029
4.4 By Type - Global Anti-Migraine Drugs Price (Manufacturers Selling Prices), 2018-2029
5 Sights by Application
5.1 Overview
5.1.1 By Application - Global Anti-Migraine Drugs Market Size, 2022 & 2029
5.1.2 Women
5.1.3 Men
5.2 By Application - Global Anti-Migraine Drugs Revenue & Forecasts
5.2.1 By Application - Global Anti-Migraine Drugs Revenue, 2018-2023
5.2.2 By Application - Global Anti-Migraine Drugs Revenue, 2024-2029
5.2.3 By Application - Global Anti-Migraine Drugs Revenue Market Share, 2018-2029
5.3 By Application - Global Anti-Migraine Drugs Sales & Forecasts
5.3.1 By Application - Global Anti-Migraine Drugs Sales, 2018-2023
5.3.2 By Application - Global Anti-Migraine Drugs Sales, 2024-2029
5.3.3 By Application - Global Anti-Migraine Drugs Sales Market Share, 2018-2029
5.4 By Application - Global Anti-Migraine Drugs Price (Manufacturers Selling Prices), 2018-2029
6 Sights by Region
6.1 By Region - Global Anti-Migraine Drugs Market Size, 2022 & 2029
6.2 By Region - Global Anti-Migraine Drugs Revenue & Forecasts
6.2.1 By Region - Global Anti-Migraine Drugs Revenue, 2018-2023
6.2.2 By Region - Global Anti-Migraine Drugs Revenue, 2024-2029
6.2.3 By Region - Global Anti-Migraine Drugs Revenue Market Share, 2018-2029
6.3 By Region - Global Anti-Migraine Drugs Sales & Forecasts
6.3.1 By Region - Global Anti-Migraine Drugs Sales, 2018-2023
6.3.2 By Region - Global Anti-Migraine Drugs Sales, 2024-2029
6.3.3 By Region - Global Anti-Migraine Drugs Sales Market Share, 2018-2029
6.4 North America
6.4.1 By Country - North America Anti-Migraine Drugs Revenue, 2018-2029
6.4.2 By Country - North America Anti-Migraine Drugs Sales, 2018-2029
6.4.3 US Anti-Migraine Drugs Market Size, 2018-2029
6.4.4 Canada Anti-Migraine Drugs Market Size, 2018-2029
6.4.5 Mexico Anti-Migraine Drugs Market Size, 2018-2029
6.5 Europe
6.5.1 By Country - Europe Anti-Migraine Drugs Revenue, 2018-2029
6.5.2 By Country - Europe Anti-Migraine Drugs Sales, 2018-2029
6.5.3 Germany Anti-Migraine Drugs Market Size, 2018-2029
6.5.4 France Anti-Migraine Drugs Market Size, 2018-2029
6.5.5 U.K. Anti-Migraine Drugs Market Size, 2018-2029
6.5.6 Italy Anti-Migraine Drugs Market Size, 2018-2029
6.5.7 Russia Anti-Migraine Drugs Market Size, 2018-2029
6.5.8 Nordic Countries Anti-Migraine Drugs Market Size, 2018-2029
6.5.9 Benelux Anti-Migraine Drugs Market Size, 2018-2029
6.6 Asia
6.6.1 By Region - Asia Anti-Migraine Drugs Revenue, 2018-2029
6.6.2 By Region - Asia Anti-Migraine Drugs Sales, 2018-2029
6.6.3 China Anti-Migraine Drugs Market Size, 2018-2029
6.6.4 Japan Anti-Migraine Drugs Market Size, 2018-2029
6.6.5 South Korea Anti-Migraine Drugs Market Size, 2018-2029
6.6.6 Southeast Asia Anti-Migraine Drugs Market Size, 2018-2029
6.6.7 India Anti-Migraine Drugs Market Size, 2018-2029
6.7 South America
6.7.1 By Country - South America Anti-Migraine Drugs Revenue, 2018-2029
6.7.2 By Country - South America Anti-Migraine Drugs Sales, 2018-2029
6.7.3 Brazil Anti-Migraine Drugs Market Size, 2018-2029
6.7.4 Argentina Anti-Migraine Drugs Market Size, 2018-2029
6.8 Middle East & Africa
6.8.1 By Country - Middle East & Africa Anti-Migraine Drugs Revenue, 2018-2029
6.8.2 By Country - Middle East & Africa Anti-Migraine Drugs Sales, 2018-2029
6.8.3 Turkey Anti-Migraine Drugs Market Size, 2018-2029
6.8.4 Israel Anti-Migraine Drugs Market Size, 2018-2029
6.8.5 Saudi Arabia Anti-Migraine Drugs Market Size, 2018-2029
6.8.6 UAE Anti-Migraine Drugs Market Size, 2018-2029
7 Manufacturers & Brands Profiles
7.1 Eli Lilly
7.1.1 Eli Lilly Company Summary
7.1.2 Eli Lilly Business Overview
7.1.3 Eli Lilly Anti-Migraine Drugs Major Product Offerings
7.1.4 Eli Lilly Anti-Migraine Drugs Sales and Revenue in Global (2018-2023)
7.1.5 Eli Lilly Key News & Latest Developments
7.2 Abbott
7.2.1 Abbott Company Summary
7.2.2 Abbott Business Overview
7.2.3 Abbott Anti-Migraine Drugs Major Product Offerings
7.2.4 Abbott Anti-Migraine Drugs Sales and Revenue in Global (2018-2023)
7.2.5 Abbott Key News & Latest Developments
7.3 Eisai
7.3.1 Eisai Company Summary
7.3.2 Eisai Business Overview
7.3.3 Eisai Anti-Migraine Drugs Major Product Offerings
7.3.4 Eisai Anti-Migraine Drugs Sales and Revenue in Global (2018-2023)
7.3.5 Eisai Key News & Latest Developments
7.4 Allergan
7.4.1 Allergan Company Summary
7.4.2 Allergan Business Overview
7.4.3 Allergan Anti-Migraine Drugs Major Product Offerings
7.4.4 Allergan Anti-Migraine Drugs Sales and Revenue in Global (2018-2023)
7.4.5 Allergan Key News & Latest Developments
7.5 Endo
7.5.1 Endo Company Summary
7.5.2 Endo Business Overview
7.5.3 Endo Anti-Migraine Drugs Major Product Offerings
7.5.4 Endo Anti-Migraine Drugs Sales and Revenue in Global (2018-2023)
7.5.5 Endo Key News & Latest Developments
7.6 GlaxoSmithKline
7.6.1 GlaxoSmithKline Company Summary
7.6.2 GlaxoSmithKline Business Overview
7.6.3 GlaxoSmithKline Anti-Migraine Drugs Major Product Offerings
7.6.4 GlaxoSmithKline Anti-Migraine Drugs Sales and Revenue in Global (2018-2023)
7.6.5 GlaxoSmithKline Key News & Latest Developments
7.7 Impax Laboratories
7.7.1 Impax Laboratories Company Summary
7.7.2 Impax Laboratories Business Overview
7.7.3 Impax Laboratories Anti-Migraine Drugs Major Product Offerings
7.7.4 Impax Laboratories Anti-Migraine Drugs Sales and Revenue in Global (2018-2023)
7.7.5 Impax Laboratories Key News & Latest Developments
7.8 Pfizer
7.8.1 Pfizer Company Summary
7.8.2 Pfizer Business Overview
7.8.3 Pfizer Anti-Migraine Drugs Major Product Offerings
7.8.4 Pfizer Anti-Migraine Drugs Sales and Revenue in Global (2018-2023)
7.8.5 Pfizer Key News & Latest Developments
7.9 AstraZeneca
7.9.1 AstraZeneca Company Summary
7.9.2 AstraZeneca Business Overview
7.9.3 AstraZeneca Anti-Migraine Drugs Major Product Offerings
7.9.4 AstraZeneca Anti-Migraine Drugs Sales and Revenue in Global (2018-2023)
7.9.5 AstraZeneca Key News & Latest Developments
7.10 Bayer
7.10.1 Bayer Company Summary
7.10.2 Bayer Business Overview
7.10.3 Bayer Anti-Migraine Drugs Major Product Offerings
7.10.4 Bayer Anti-Migraine Drugs Sales and Revenue in Global (2018-2023)
7.10.5 Bayer Key News & Latest Developments
7.11 Johnson & Johnson
7.11.1 Johnson & Johnson Company Summary
7.11.2 Johnson & Johnson Anti-Migraine Drugs Business Overview
7.11.3 Johnson & Johnson Anti-Migraine Drugs Major Product Offerings
7.11.4 Johnson & Johnson Anti-Migraine Drugs Sales and Revenue in Global (2018-2023)
7.11.5 Johnson & Johnson Key News & Latest Developments
7.12 Merck
7.12.1 Merck Company Summary
7.12.2 Merck Anti-Migraine Drugs Business Overview
7.12.3 Merck Anti-Migraine Drugs Major Product Offerings
7.12.4 Merck Anti-Migraine Drugs Sales and Revenue in Global (2018-2023)
7.12.5 Merck Key News & Latest Developments
7.13 Teva
7.13.1 Teva Company Summary
7.13.2 Teva Anti-Migraine Drugs Business Overview
7.13.3 Teva Anti-Migraine Drugs Major Product Offerings
7.13.4 Teva Anti-Migraine Drugs Sales and Revenue in Global (2018-2023)
7.13.5 Teva Key News & Latest Developments
7.14 Amgen
7.14.1 Amgen Company Summary
7.14.2 Amgen Business Overview
7.14.3 Amgen Anti-Migraine Drugs Major Product Offerings
7.14.4 Amgen Anti-Migraine Drugs Sales and Revenue in Global (2018-2023)
7.14.5 Amgen Key News & Latest Developments
8 Global Anti-Migraine Drugs Production Capacity, Analysis
8.1 Global Anti-Migraine Drugs Production Capacity, 2018-2029
8.2 Anti-Migraine Drugs Production Capacity of Key Manufacturers in Global Market
8.3 Global Anti-Migraine Drugs Production by Region
9 Key Market Trends, Opportunity, Drivers and Restraints
9.1 Market Opportunities & Trends
9.2 Market Drivers
9.3 Market Restraints
10 Anti-Migraine Drugs Supply Chain Analysis
10.1 Anti-Migraine Drugs Industry Value Chain
10.2 Anti-Migraine Drugs Upstream Market
10.3 Anti-Migraine Drugs Downstream and Clients
10.4 Marketing Channels Analysis
10.4.1 Marketing Channels
10.4.2 Anti-Migraine Drugs Distributors and Sales Agents in Global
11 Conclusion
12 Appendix
12.1 Note
12.2 Examples of Clients
12.3 Disclaimer
LIST OF TABLES & FIGURES
List of Tables
Table 1. Key Players of Anti-Migraine Drugs in Global Market
Table 2. Top Anti-Migraine Drugs Players in Global Market, Ranking by Revenue (2022)
Table 3. Global Anti-Migraine Drugs Revenue by Companies, (US$, Mn), 2018-2023
Table 4. Global Anti-Migraine Drugs Revenue Share by Companies, 2018-2023
Table 5. Global Anti-Migraine Drugs Sales by Companies, (K Units), 2018-2023
Table 6. Global Anti-Migraine Drugs Sales Share by Companies, 2018-2023
Table 7. Key Manufacturers Anti-Migraine Drugs Price (2018-2023) & (USD/Pcs)
Table 8. Global Manufacturers Anti-Migraine Drugs Product Type
Table 9. List of Global Tier 1 Anti-Migraine Drugs Companies, Revenue (US$, Mn) in 2022 and Market Share
Table 10. List of Global Tier 2 and Tier 3 Anti-Migraine Drugs Companies, Revenue (US$, Mn) in 2022 and Market Share
Table 11. By Type ? Global Anti-Migraine Drugs Revenue, (US$, Mn), 2022 & 2029
Table 12. By Type - Global Anti-Migraine Drugs Revenue (US$, Mn), 2018-2023
Table 13. By Type - Global Anti-Migraine Drugs Revenue (US$, Mn), 2024-2029
Table 14. By Type - Global Anti-Migraine Drugs Sales (K Units), 2018-2023
Table 15. By Type - Global Anti-Migraine Drugs Sales (K Units), 2024-2029
Table 16. By Application ? Global Anti-Migraine Drugs Revenue, (US$, Mn), 2022 & 2029
Table 17. By Application - Global Anti-Migraine Drugs Revenue (US$, Mn), 2018-2023
Table 18. By Application - Global Anti-Migraine Drugs Revenue (US$, Mn), 2024-2029
Table 19. By Application - Global Anti-Migraine Drugs Sales (K Units), 2018-2023
Table 20. By Application - Global Anti-Migraine Drugs Sales (K Units), 2024-2029
Table 21. By Region ? Global Anti-Migraine Drugs Revenue, (US$, Mn), 2022 VS 2029
Table 22. By Region - Global Anti-Migraine Drugs Revenue (US$, Mn), 2018-2023
Table 23. By Region - Global Anti-Migraine Drugs Revenue (US$, Mn), 2024-2029
Table 24. By Region - Global Anti-Migraine Drugs Sales (K Units), 2018-2023
Table 25. By Region - Global Anti-Migraine Drugs Sales (K Units), 2024-2029
Table 26. By Country - North America Anti-Migraine Drugs Revenue, (US$, Mn), 2018-2023
Table 27. By Country - North America Anti-Migraine Drugs Revenue, (US$, Mn), 2024-2029
Table 28. By Country - North America Anti-Migraine Drugs Sales, (K Units), 2018-2023
Table 29. By Country - North America Anti-Migraine Drugs Sales, (K Units), 2024-2029
Table 30. By Country - Europe Anti-Migraine Drugs Revenue, (US$, Mn), 2018-2023
Table 31. By Country - Europe Anti-Migraine Drugs Revenue, (US$, Mn), 2024-2029
Table 32. By Country - Europe Anti-Migraine Drugs Sales, (K Units), 2018-2023
Table 33. By Country - Europe Anti-Migraine Drugs Sales, (K Units), 2024-2029
Table 34. By Region - Asia Anti-Migraine Drugs Revenue, (US$, Mn), 2018-2023
Table 35. By Region - Asia Anti-Migraine Drugs Revenue, (US$, Mn), 2024-2029
Table 36. By Region - Asia Anti-Migraine Drugs Sales, (K Units), 2018-2023
Table 37. By Region - Asia Anti-Migraine Drugs Sales, (K Units), 2024-2029
Table 38. By Country - South America Anti-Migraine Drugs Revenue, (US$, Mn), 2018-2023
Table 39. By Country - South America Anti-Migraine Drugs Revenue, (US$, Mn), 2024-2029
Table 40. By Country - South America Anti-Migraine Drugs Sales, (K Units), 2018-2023
Table 41. By Country - South America Anti-Migraine Drugs Sales, (K Units), 2024-2029
Table 42. By Country - Middle East & Africa Anti-Migraine Drugs Revenue, (US$, Mn), 2018-2023
Table 43. By Country - Middle East & Africa Anti-Migraine Drugs Revenue, (US$, Mn), 2024-2029
Table 44. By Country - Middle East & Africa Anti-Migraine Drugs Sales, (K Units), 2018-2023
Table 45. By Country - Middle East & Africa Anti-Migraine Drugs Sales, (K Units), 2024-2029
Table 46. Eli Lilly Company Summary
Table 47. Eli Lilly Anti-Migraine Drugs Product Offerings
Table 48. Eli Lilly Anti-Migraine Drugs Sales (K Units), Revenue (US$, Mn) and Average Price (USD/Pcs) (2018-2023)
Table 49. Eli Lilly Key News & Latest Developments
Table 50. Abbott Company Summary
Table 51. Abbott Anti-Migraine Drugs Product Offerings
Table 52. Abbott Anti-Migraine Drugs Sales (K Units), Revenue (US$, Mn) and Average Price (USD/Pcs) (2018-2023)
Table 53. Abbott Key News & Latest Developments
Table 54. Eisai Company Summary
Table 55. Eisai Anti-Migraine Drugs Product Offerings
Table 56. Eisai Anti-Migraine Drugs Sales (K Units), Revenue (US$, Mn) and Average Price (USD/Pcs) (2018-2023)
Table 57. Eisai Key News & Latest Developments
Table 58. Allergan Company Summary
Table 59. Allergan Anti-Migraine Drugs Product Offerings
Table 60. Allergan Anti-Migraine Drugs Sales (K Units), Revenue (US$, Mn) and Average Price (USD/Pcs) (2018-2023)
Table 61. Allergan Key News & Latest Developments
Table 62. Endo Company Summary
Table 63. Endo Anti-Migraine Drugs Product Offerings
Table 64. Endo Anti-Migraine Drugs Sales (K Units), Revenue (US$, Mn) and Average Price (USD/Pcs) (2018-2023)
Table 65. Endo Key News & Latest Developments
Table 66. GlaxoSmithKline Company Summary
Table 67. GlaxoSmithKline Anti-Migraine Drugs Product Offerings
Table 68. GlaxoSmithKline Anti-Migraine Drugs Sales (K Units), Revenue (US$, Mn) and Average Price (USD/Pcs) (2018-2023)
Table 69. GlaxoSmithKline Key News & Latest Developments
Table 70. Impax Laboratories Company Summary
Table 71. Impax Laboratories Anti-Migraine Drugs Product Offerings
Table 72. Impax Laboratories Anti-Migraine Drugs Sales (K Units), Revenue (US$, Mn) and Average Price (USD/Pcs) (2018-2023)
Table 73. Impax Laboratories Key News & Latest Developments
Table 74. Pfizer Company Summary
Table 75. Pfizer Anti-Migraine Drugs Product Offerings
Table 76. Pfizer Anti-Migraine Drugs Sales (K Units), Revenue (US$, Mn) and Average Price (USD/Pcs) (2018-2023)
Table 77. Pfizer Key News & Latest Developments
Table 78. AstraZeneca Company Summary
Table 79. AstraZeneca Anti-Migraine Drugs Product Offerings
Table 80. AstraZeneca Anti-Migraine Drugs Sales (K Units), Revenue (US$, Mn) and Average Price (USD/Pcs) (2018-2023)
Table 81. AstraZeneca Key News & Latest Developments
Table 82. Bayer Company Summary
Table 83. Bayer Anti-Migraine Drugs Product Offerings
Table 84. Bayer Anti-Migraine Drugs Sales (K Units), Revenue (US$, Mn) and Average Price (USD/Pcs) (2018-2023)
Table 85. Bayer Key News & Latest Developments
Table 86. Johnson & Johnson Company Summary
Table 87. Johnson & Johnson Anti-Migraine Drugs Product Offerings
Table 88. Johnson & Johnson Anti-Migraine Drugs Sales (K Units), Revenue (US$, Mn) and Average Price (USD/Pcs) (2018-2023)
Table 89. Johnson & Johnson Key News & Latest Developments
Table 90. Merck Company Summary
Table 91. Merck Anti-Migraine Drugs Product Offerings
Table 92. Merck Anti-Migraine Drugs Sales (K Units), Revenue (US$, Mn) and Average Price (USD/Pcs) (2018-2023)
Table 93. Merck Key News & Latest Developments
Table 94. Teva Company Summary
Table 95. Teva Anti-Migraine Drugs Product Offerings
Table 96. Teva Anti-Migraine Drugs Sales (K Units), Revenue (US$, Mn) and Average Price (USD/Pcs) (2018-2023)
Table 97. Teva Key News & Latest Developments
Table 98. Amgen Company Summary
Table 99. Amgen Anti-Migraine Drugs Product Offerings
Table 100. Amgen Anti-Migraine Drugs Sales (K Units), Revenue (US$, Mn) and Average Price (USD/Pcs) (2018-2023)
Table 101. Amgen Key News & Latest Developments
Table 102. Anti-Migraine Drugs Production Capacity (K Units) of Key Manufacturers in Global Market, 2021-2023 (K Units)
Table 103. Global Anti-Migraine Drugs Capacity Market Share of Key Manufacturers, 2021-2023
Table 104. Global Anti-Migraine Drugs Production by Region, 2018-2023 (K Units)
Table 105. Global Anti-Migraine Drugs Production by Region, 2024-2029 (K Units)
Table 106. Anti-Migraine Drugs Market Opportunities & Trends in Global Market
Table 107. Anti-Migraine Drugs Market Drivers in Global Market
Table 108. Anti-Migraine Drugs Market Restraints in Global Market
Table 109. Anti-Migraine Drugs Raw Materials
Table 110. Anti-Migraine Drugs Raw Materials Suppliers in Global Market
Table 111. Typical Anti-Migraine Drugs Downstream
Table 112. Anti-Migraine Drugs Downstream Clients in Global Market
Table 113. Anti-Migraine Drugs Distributors and Sales Agents in Global Market
List of Figures
Figure 1. Anti-Migraine Drugs Segment by Type in 2022
Figure 2. Anti-Migraine Drugs Segment by Application in 2022
Figure 3. Global Anti-Migraine Drugs Market Overview: 2022
Figure 4. Key Caveats
Figure 5. Global Anti-Migraine Drugs Market Size: 2022 VS 2029 (US$, Mn)
Figure 6. Global Anti-Migraine Drugs Revenue, 2018-2029 (US$, Mn)
Figure 7. Anti-Migraine Drugs Sales in Global Market: 2018-2029 (K Units)
Figure 8. The Top 3 and 5 Players Market Share by Anti-Migraine Drugs Revenue in 2022
Figure 9. By Type - Global Anti-Migraine Drugs Revenue, (US$, Mn), 2022 & 2029
Figure 10. By Type - Global Anti-Migraine Drugs Revenue Market Share, 2018-2029
Figure 11. By Type - Global Anti-Migraine Drugs Sales Market Share, 2018-2029
Figure 12. By Type - Global Anti-Migraine Drugs Price (USD/Pcs), 2018-2029
Figure 13. By Application - Global Anti-Migraine Drugs Revenue, (US$, Mn), 2022 & 2029
Figure 14. By Application - Global Anti-Migraine Drugs Revenue Market Share, 2018-2029
Figure 15. By Application - Global Anti-Migraine Drugs Sales Market Share, 2018-2029
Figure 16. By Application - Global Anti-Migraine Drugs Price (USD/Pcs), 2018-2029
Figure 17. By Region - Global Anti-Migraine Drugs Revenue, (US$, Mn), 2022 & 2029
Figure 18. By Region - Global Anti-Migraine Drugs Revenue Market Share, 2018 VS 2022 VS 2029
Figure 19. By Region - Global Anti-Migraine Drugs Revenue Market Share, 2018-2029
Figure 20. By Region - Global Anti-Migraine Drugs Sales Market Share, 2018-2029
Figure 21. By Country - North America Anti-Migraine Drugs Revenue Market Share, 2018-2029
Figure 22. By Country - North America Anti-Migraine Drugs Sales Market Share, 2018-2029
Figure 23. US Anti-Migraine Drugs Revenue, (US$, Mn), 2018-2029
Figure 24. Canada Anti-Migraine Drugs Revenue, (US$, Mn), 2018-2029
Figure 25. Mexico Anti-Migraine Drugs Revenue, (US$, Mn), 2018-2029
Figure 26. By Country - Europe Anti-Migraine Drugs Revenue Market Share, 2018-2029
Figure 27. By Country - Europe Anti-Migraine Drugs Sales Market Share, 2018-2029
Figure 28. Germany Anti-Migraine Drugs Revenue, (US$, Mn), 2018-2029
Figure 29. France Anti-Migraine Drugs Revenue, (US$, Mn), 2018-2029
Figure 30. U.K. Anti-Migraine Drugs Revenue, (US$, Mn), 2018-2029
Figure 31. Italy Anti-Migraine Drugs Revenue, (US$, Mn), 2018-2029
Figure 32. Russia Anti-Migraine Drugs Revenue, (US$, Mn), 2018-2029
Figure 33. Nordic Countries Anti-Migraine Drugs Revenue, (US$, Mn), 2018-2029
Figure 34. Benelux Anti-Migraine Drugs Revenue, (US$, Mn), 2018-2029
Figure 35. By Region - Asia Anti-Migraine Drugs Revenue Market Share, 2018-2029
Figure 36. By Region - Asia Anti-Migraine Drugs Sales Market Share, 2018-2029
Figure 37. China Anti-Migraine Drugs Revenue, (US$, Mn), 2018-2029
Figure 38. Japan Anti-Migraine Drugs Revenue, (US$, Mn), 2018-2029
Figure 39. South Korea Anti-Migraine Drugs Revenue, (US$, Mn), 2018-2029
Figure 40. Southeast Asia Anti-Migraine Drugs Revenue, (US$, Mn), 2018-2029
Figure 41. India Anti-Migraine Drugs Revenue, (US$, Mn), 2018-2029
Figure 42. By Country - South America Anti-Migraine Drugs Revenue Market Share, 2018-2029
Figure 43. By Country - South America Anti-Migraine Drugs Sales Market Share, 2018-2029
Figure 44. Brazil Anti-Migraine Drugs Revenue, (US$, Mn), 2018-2029
Figure 45. Argentina Anti-Migraine Drugs Revenue, (US$, Mn), 2018-2029
Figure 46. By Country - Middle East & Africa Anti-Migraine Drugs Revenue Market Share, 2018-2029
Figure 47. By Country - Middle East & Africa Anti-Migraine Drugs Sales Market Share, 2018-2029
Figure 48. Turkey Anti-Migraine Drugs Revenue, (US$, Mn), 2018-2029
Figure 49. Israel Anti-Migraine Drugs Revenue, (US$, Mn), 2018-2029
Figure 50. Saudi Arabia Anti-Migraine Drugs Revenue, (US$, Mn), 2018-2029
Figure 51. UAE Anti-Migraine Drugs Revenue, (US$, Mn), 2018-2029
Figure 52. Global Anti-Migraine Drugs Production Capacity (K Units), 2018-2029
Figure 53. The Percentage of Production Anti-Migraine Drugs by Region, 2022 VS 2029
Figure 54. Anti-Migraine Drugs Industry Value Chain
Figure 55. Marketing Channels
